'Thriving With Bipolar Disorder': Co-design and Evaluation of a Peer-Led Education Program Focused on Quality of Life
Launched by UNIVERSITY OF BRITISH COLUMBIA · Mar 10, 2025
Trial Information
Current as of July 31, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Thriving with Bipolar Disorder," is designed to explore how a new education program can help people with bipolar disorder (BD) improve their quality of life (QoL). The program will be run by trained peers—people who also live with BD and have learned how to manage their symptoms effectively. By sharing their experiences and strategies, these peer facilitators aim to provide valuable support and information in a group setting. The trial will evaluate how well the program works and how participants feel about it.
To be eligible for this program, participants need to be at least 18 years old, live in Canada, and have a self-reported diagnosis of bipolar disorder. They must also be able to read, write, and speak English, and have access to a device like a computer or smartphone for online meetings. Participants can expect to engage in discussions, learn new self-management techniques, and connect with others who share similar experiences. This unique approach focuses on improving daily life for those living with BD, making it a supportive and informative opportunity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Program facilitators
- • aged 18 or older
- • a self-reported diagnosis of a mood disorder
- • sufficient access to an internet-enabled computer or smartphone device to access the Zoom teleconferencing platform
- • ability to understand, read and write English
- • at least one year of prior experience leading peer support groups or recovery programs through Hope+Me
- • previously received training through Hope+Me
- • completed a Criminal Records Check
- • 2. Program participants
- • aged 18 or older
- • residing in Canada
- • a self-reported diagnosis of BD
- • ability to understand, read and write English
- • sufficient access to an internet-enabled computer or smartphone device to access the Zoom teleconferencing platform
- Exclusion Criteria:
- • inability to communicate in written and verbal English to a sufficient level to allow participation in the program and research activities
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported